TC Biopharm (Holdings) Plc Sponsored ADR (TCBP) has released an update.
TC Biopharm (Holdings) Plc has been notified by Nasdaq that its stock price has fallen below the $1 minimum bid requirement for 30 consecutive days, putting the company at risk of delisting. The company, also not in compliance with Nasdaq’s minimum stockholders’ equity requirement as of March 31, 2024, has been granted until August 15, 2024, to meet this requirement after a hearing with Nasdaq. TC Biopharm must now convince the Nasdaq panel of its compliance to maintain its listing, but there is no certainty of a favorable outcome.
For further insights into TCBP stock, check out TipRanks’ Stock Analysis page.
